An in-depth look to NEXTCELL PHARMA AB operating, investing, and financing activities

NXTCL free cash flow for Q4 24 is -7.95 M SEK. For 2024, NXTCL free cash flow was -37.86 M SEK and operating cash flow was -37.78 M SEK.